Bioventus (BVS) Cash from Investing Activities (QoQ) (2020 - 2026)
Bioventus (BVS) Cash from Investing Activities (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn |
| 10 | Bioventus | 964.42 Mn | 934.96 Mn | 105.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | -328.57% |
| Mar 28, 2026 | 1.03% |
| Dec 31, 2025 | -22.62% |
| Sep 27, 2025 | 65.45% |
| Jun 28, 2025 | -65.74% |
| Mar 29, 2025 | -103.43% |
| Dec 31, 2024 | 37,762.50% |
| Sep 28, 2024 | 16.88% |
| Jun 29, 2024 | 92.30% |
| Mar 30, 2024 | -69.20% |
| Dec 31, 2023 | 70.97% |
| Sep 30, 2023 | -104.52% |
| Jul 1, 2023 | 398.73% |
| Apr 1, 2023 | -342.73% |
| Dec 31, 2022 | 93.96% |
| Oct 1, 2022 | -8.28% |
| Jul 2, 2022 | -1,013.07% |
| Apr 2, 2022 | 97.89% |
| Dec 31, 2021 | -1,578.13% |
| Oct 2, 2021 | -397.96% |